AIMS/HYPOTHESIS: The stress-activated nuclear protein transcription regulator 1 (NUPR1) is induced in response to glucose and TNF-α, both of which are elevated in type 2 diabetes, and Nupr1 has been implicated in cell proliferation and apoptosis cascades. We used Nupr1(-/-) mice to study the role of Nupr1 in glucose homeostasis under normal conditions and following maintenance on a high-fat diet (HFD). METHODS: Glucose homeostasis in vivo was determined by measuring glucose tolerance, insulin sensitivity and insulin secretion. Islet number, morphology and beta cell area were assessed by immunofluorescence and morphometric analysis, and islet cell proliferation was quantified by analysis of BrdU incorporation. Islet gene expression was measured by gene arrays and quantitative RT-PCR, and gene promoter activities were monitored by measuring luciferase activity. RESULTS: Nupr1(-/-) mice had increased beta cell mass as a consequence of enhanced islet cell proliferation. Nupr1-dependent suppression of beta cell Ccna2 and Tcf19 promoter activities was identified as a mechanism through which Nupr1 may regulate beta cell cycle progression. Nupr1(-/-) mice maintained on a normal diet were mildly insulin resistant, but were normoglycaemic with normal glucose tolerance because of compensatory increases in basal and glucose-induced insulin secretion. Nupr1 deletion was protective against HFD-induced obesity, insulin resistance and glucose intolerance. CONCLUSIONS/ INTERPRETATION: Inhibition of NUPR1 expression or activity has the potential to protect against the metabolic defects associated with obesity and type 2 diabetes.
AIMS/HYPOTHESIS: The stress-activated nuclear protein transcription regulator 1 (NUPR1) is induced in response to glucose and TNF-α, both of which are elevated in type 2 diabetes, and Nupr1 has been implicated in cell proliferation and apoptosis cascades. We used Nupr1(-/-) mice to study the role of Nupr1 in glucose homeostasis under normal conditions and following maintenance on a high-fat diet (HFD). METHODS: Glucose homeostasis in vivo was determined by measuring glucose tolerance, insulin sensitivity and insulin secretion. Islet number, morphology and beta cell area were assessed by immunofluorescence and morphometric analysis, and islet cell proliferation was quantified by analysis of BrdU incorporation. Islet gene expression was measured by gene arrays and quantitative RT-PCR, and gene promoter activities were monitored by measuring luciferase activity. RESULTS: Nupr1(-/-) mice had increased beta cell mass as a consequence of enhanced islet cell proliferation. Nupr1-dependent suppression of beta cell Ccna2 and Tcf19 promoter activities was identified as a mechanism through which Nupr1 may regulate beta cell cycle progression. Nupr1(-/-) mice maintained on a normal diet were mildly insulin resistant, but were normoglycaemic with normal glucose tolerance because of compensatory increases in basal and glucose-induced insulin secretion. Nupr1 deletion was protective against HFD-induced obesity, insulin resistance and glucose intolerance. CONCLUSIONS/ INTERPRETATION: Inhibition of NUPR1 expression or activity has the potential to protect against the metabolic defects associated with obesity and type 2 diabetes.
Authors: Guo Cai Huang; Min Zhao; Peter Jones; Shanta Persaud; Reshma Ramracheya; Kristian Löbner; Michael R Christie; J Paul Banga; Mark Peakman; Parthi Sirinivsan; Mohammed Rela; Nigel Heaton; Stephanie Amiel Journal: Transplantation Date: 2004-01-15 Impact factor: 4.939
Authors: Roxane M Pommier; Johann Gout; David F Vincent; Carla E Cano; Bastien Kaniewski; Sylvie Martel; Jonathan Rodriguez; Geneviève Fourel; Ulrich Valcourt; Julien C Marie; Juan L Iovanna; Laurent Bartholin Journal: Biochem J Date: 2012-07-15 Impact factor: 3.857
Authors: Günter Päth; Amir E Mehana; Ingo H Pilz; Marcus Alt; Johannes Baumann; Ines Sommerer; Albrecht Hoffmeister; Jochen Seufert Journal: Am J Physiol Endocrinol Metab Date: 2020-06-23 Impact factor: 4.310
Authors: Adriano Maida; Annika Zota; Kim A Sjøberg; Jonas Schumacher; Tjeerd P Sijmonsma; Anja Pfenninger; Marie M Christensen; Thomas Gantert; Jessica Fuhrmeister; Ulrike Rothermel; Dieter Schmoll; Mathias Heikenwälder; Juan L Iovanna; Kerstin Stemmer; Bente Kiens; Stephan Herzig; Adam J Rose Journal: J Clin Invest Date: 2016-08-22 Impact factor: 14.808
Authors: Marcus Hollenbach; Nora Klöting; Ines Sommerer; Jana Lorenz; Mario Heindl; Matthias Kern; Joachim Mössner; Matthias Blüher; Albrecht Hoffmeister Journal: PLoS One Date: 2018-07-24 Impact factor: 3.240